Herbal tea may soothe bladder cancer Patients' urinary woes
NCT ID NCT05739071
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether JING SI HERBAL TEA, a dietary supplement with herbal extracts, can ease lower urinary tract symptoms in bladder cancer patients who have received intravesical therapy. One hundred participants will receive either the herbal tea or a placebo, and their urinary symptoms and quality of life will be tracked. The goal is to see if this natural drink can provide relief without interfering with standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JING SI HERBAL TEA (a dietary supplement with herbal extracts)
- What this could lead to
- If it works, this could offer a natural way to reduce urinary discomfort after bladder cancer treatment.
- What could go wrong
- This is a small, early-stage trial with no phase designation, so results may not be conclusive. The supplement may not outperform placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Buddhist Tzu Chi General Hospital, Taipei branch
Taipei, Taiwan, 231, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Bag-Like device pull bladder tumors out whole?
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Could a simple urine test spare bladder cancer patients from chemotherapy?
- Can a fluid injection make prostate surgery safer and less bloody?
- Can a new drug rally the immune system against Hard-to-Treat cancers?